POS13 THE ESTIMATION OF COST–EFFECTIVENESS THRESHOLDS PRIOR TO THE START OF LARGE CLINICAL STUDIES
Abstract
Authors
TP Van Staa C Cooper HG Leufkens
TP Van Staa C Cooper HG Leufkens
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now